Panacea Biotec

Panacea Biotec shares rally sharply over 4% after securing contract worth Rs 315 crore from UNICEF

Panacea Biotec bags order worth Rs 315 crore for supply of oral polio vaccine from UNICEF

Panacea Biotec’s EmulsiPan listed in CEPI Adjuvant Library to support vaccine development

Panacea Biotec shares hit 5% upper circuit after additional UNICEF vaccine order worth Rs 44 crore

Panacea Biotec secures additional $5.2 million polio vaccine order from UNICEF

Panacea Biotec subsidiary launches baby care products under “NikoMom” brand

Panacea Biotec shares hit 5% upper circuit after securing Rs 127 crore vaccine supply contract from UNICEF

Panacea Biotec secures Rs 127 crore UNICEF order for bivalent oral polio vaccine

Panacea Biotec shares surge 4% as company set to launch dengue vaccine in next 2-3 years

Panacea Biotec shares surge over 3% in intraday trading

Panacea Biotec to produce 25 million doses of Sputnik V COVID-19 vaccine in India

The pharmaceutical company will supply the doses to Dr Reddy’s Laboratories to distribute it across the country.

COVID-19 Vaccine: India’s Panacea Biotec aims to produce 100 million doses of Sputnik V annually

Production of Sputnik V at Panacea Biotec sites will help facilitate global supply of Sputnik V to international partners of RDIF.